Medtronic to Acquire CoreValve

Medtronic has signed an agreement to acquire CoreValve for $700 million. CoreValve’s ReValving system offers a nonsurgical alternative for patients to have aortic valves replaced using a catheter inserted through an artery in the groin. The agreement calls for additional payments contingent upon achievement of specified milestones, Medtronic said.